Precipio Inc
$ 22.42
4.28%
12 Feb - close price
- Market Cap 31,614,300 USD
- Current Price $ 22.42
- High / Low $ 22.94 / 21.50
- Stock P/E N/A
- Book Value 8.10
- EPS -1.19
- Next Earning Report 2026-03-26
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.09 %
- ROE -0.15 %
- 52 Week High 28.50
- 52 Week Low 3.90
About
Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market. The company is headquartered in New Haven, Connecticut.
Analyst Target Price
$19.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-14 | 2025-08-13 | 2025-05-12 | 2025-03-31 | 2024-11-11 | 2024-08-13 | 2024-05-14 | 2023-11-13 | 2023-08-11 | 2023-05-12 | 2023-03-30 | 2022-11-10 |
| Reported EPS | -0.05 | 0.05 | -0.5883 | -0.2444 | -0.4229 | -0.8336 | 0.6514 | -1.04 | -0.09 | -0.13 | -0.1 | -0.14 |
| Estimated EPS | None | None | None | 0.74 | None | None | None | -1.21 | -0.1 | -0.13 | -0.14 | -0.04 |
| Surprise | 0 | 0 | 0 | -0.9844 | 0 | 0 | 0 | 0.17 | 0.01 | 0 | 0.04 | -0.1 |
| Surprise Percentage | None% | None% | None% | -133.027% | None% | None% | None% | 14.0496% | 10% | 0% | 28.5714% | -250% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-26 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PRPO
2026-02-11 18:58:01
Strauss Borrelli PLLC is investigating Precipio, Inc. following a recent data breach that compromised sensitive personal information and protected health information. The breach occurred when an unauthorized user accessed an employee's cloud-based storage account on November 25, 2025, potentially exposing data like names, addresses, health information, and more. Precipio, a cancer diagnostics company, has begun notifying affected individuals, and those who received a breach notification letter are encouraged to contact Strauss Borrelli to discuss their legal rights.
2026-02-11 15:58:01
New Haven-based biotech company Precipio Inc. has reported a data breach that occurred in November 2025, potentially affecting over 500 people. The incident, reported to federal authorities on January 23, involved an unauthorized user accessing an employee's cloud-based storage account and copying certain files. While an investigation determined the breach was limited and did not include patient Social Security numbers or proprietary company data, the company continues to assess the situation.
2026-02-10 17:58:52
Precipio, a diagnostic services firm, has confirmed a significant cybersecurity breach where the ransomware group "INC RANSOM" exfiltrated 150 gigabytes of sensitive patient data, including PII and PHI, through a compromised employee cloud storage account. While core operations are reportedly unaffected, the incident raises serious concerns about data security within the healthcare sector and is expected to lead to regulatory scrutiny from the U.S. Department of Health and Human Services. The company has already notified HHS and is providing guidance for affected individuals.
2026-02-10 13:29:06
Precipio, Pit River Health Service, and Tulane University Medical Group have all confirmed recent data breaches. Precipio experienced unauthorized access to an employee's cloud account, potentially compromising sensitive patient data, while Pit River Health Service's systems were hacked, affecting up to 1,800 individuals. Tulane University Medical Group reported a ransomware attack by the Cl0p group, impacting the protected health information of 6,530 patients.
2026-02-03 20:58:45
Precipio, a healthcare diagnostics company, experienced a data breach where an unauthorized user accessed an employee's cloud-based storage, leading to 150 GB of PHI and PII being compromised. The INC RANSOM group claimed responsibility for the attack, which exposed sensitive information including names, addresses, medical records, and health insurance details. Precipio has secured the account, launched an investigation, notified federal law enforcement, and is advising affected individuals to monitor for identity theft and fraud.
2026-02-03 20:58:45
Shamis & Gentile P.A. is investigating a data breach at Precipio, Inc., a healthcare biotechnology company. The breach occurred in November 2025, when an unauthorized user accessed an employee's cloud storage, exposing sensitive personal and medical information. Affected individuals may be entitled to compensation and are advised to monitor their accounts and consider legal action.
